Tycel Phillips, MD, of the City of Hope, talks about the TRIANGLE study and frontline therapy in mantle cell lymphoma on The HemOnc Pulse, a podcast from Blood Cancers Today and the Society of Hematologic Oncology.
The HemOnc Pulse Live at ASH: Tycel Phillips, MD, on the TRIANGLE Study, Frontline Therapy in MCL
By Chadi Nabhan, MD, MBA, FACP, Tycel Phillips, MD - Last Updated: January 10, 2023Post Tags:Lymphoma ASH 22
Related Posts
FDA shifts to real-time FAERS reporting, aiming to boost transparency in drug safety but raising concerns on data use.
Cardiovascular complications, such as those associated with arterial or venous thromboembolism, are a prominent concern.
In the RELATIVITY-022 study, the combination's efficacy was greatest in Hodgkin lymphomas naive to PD-1 or PD-L1 inhibition.
Guest contributor Charles Gaulin, MBBS, outlines important updates on the first-line treatment of TP53-mutated MCL.
Gaps in coordination and collaboration between primary care and oncology may impact long-term survival outcomes for patients.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.